Tizanidne Hydrochloride Capsule
Product Images NDC 63629-8871

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Tizanidne Hydrochloride (NDC 63629-8871). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (Lbl636298871)

This is a description of a medication called Tizanidine Hydrochloride Capsules. Each capsule contains 2.29 mg tizanidine hydrochloride equivalent to 2 mg tizanidine base. The medication should be kept out of reach of children and stored at 25°C (77°F). The medication should be dispensed in a tight container with a child-resistant closure. The medication is not interchangeable with tizanidine tablets or Zanaflex tablets. The NDC for this medication is 63629-8871-1, and it is manufactured by BRP Pharmaceuticals.*

FDA Label Image

Tiz01 (Tiz01)

FDA Label Image

Tiz02 (Tiz02)

FDA Label Image

Tiz03 (Tiz03)

FDA Label Image

Tiz04 (Tiz04)

This text appears to be a chart displaying the Improvement in Ashworth Score over time for a study involving Tizanidine, with the mean dose being 26.8 mg. It also shows the progression through the titration and maintenance phases of the study.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.